Anti-oxidative and Anti-cancer Activities by Cell Cycle Regulation of Salsola collina Extract
![]() |
Oh, You Na
(Blue-Bio Industry Regional Innovation Center, Dong-Eui University)
Jin, Soojung (Blue-Bio Industry Regional Innovation Center, Dong-Eui University) Park, Hyun-Jin (Blue-Bio Industry Regional Innovation Center, Dong-Eui University) Kwon, Hyun Ju (Blue-Bio Industry Regional Innovation Center, Dong-Eui University) Kim, Byung Woo (Blue-Bio Industry Regional Innovation Center, Dong-Eui University) |
1 | Cha MR, Yoon MY, Kim JY, Hwang JH, Park HR. 2006. The cytotoxic effect of the Gleditsiae semen extracts oh human colon carcinoma cells. J. Korean Soc. Appl. Biol. Chem. 49: 248-253. |
2 | Chang CH, Yu FY, Wu TS, Wang LT, Liu BH. 2011. Mycotoxin citrinin induced cell cycle G2/M arrest and numerical chromosomal aberration associated with disruption of microtubule formation in human cells. Toxicol. Sci. 119: 84-92. DOI ScienceOn |
3 | Donzelli M, Draetta GF. 2003. Regulating mammalian checkpoints through Cdc25 inactivation. EMBO Reports 4: 671-677. DOI ScienceOn |
4 | Dorai T, Aggarwal BB. 2004. Role of chemopreventive agents in cancer therapy. Cancer Lett. 215: 120-140. |
5 | Dulic V, Stein GH, Far DF, Reed SI. 1998. Nuclear accumulation of p21Cip1 at the onset of mitosis: a role at the G2/M-phase transition. Mol. Cell. Biol. 18: 546-557. DOI |
6 | Elledge SJ, Harper JW. 1994. Cdk inhibitors: on the threshold of checkpoints and development. Curr. Opin. Cell Biol. 6: 847-852. DOI ScienceOn |
7 | Aktas H, Cai H, Cooper GM. 1997. Ras links growth factor signaling to the cell cycle machinery via regulation of cyclin D1 and the Cdk inhibitor p27KIP1. Mol. Cell. Biol. 17: 3850-3857. DOI |
8 | Albert H, Santos S, Battaglia E, Brito M, Monteiro C, Bagrel D. 2011. Differential expression of CDC25 phosphatases splice variants in human breast cancer cells. Clin. Chem. Lab. Med. 49: 1707-1714. |
9 | Sherr CJ. 1996. Cancer cell cycles. Science 274: 1672-1677. DOI ScienceOn |
10 | Park JY, Kang KS, Sohn YK. 2010. Molecular mechanism of the G2/M arrest in breast cancer cell lines (T47D and MDAMB231) induced by Genistein. J. Breast Cancer 13: 382-391. DOI |
11 | Reiter RJ. 1995. Oxidative processes and antioxidative defense mechanisms in the aging brain. FASEB J. 9: 526-533. DOI |
12 | Tchou WW, Rom WN, Tchou-Wong KM. 1996. Novel form of p21WAF1/CIP1/SDI1 protein in phorbol ester induced G2/M arrest. J. Biol. Chem. 271: 29556-29560. DOI ScienceOn |
13 | Seo GS. 2011. The role of NF-kB in colon cancer. Korean J. Gastroenterol. 57: 3-7. DOI |
14 | Shi J, Gong J, Liu J, Wu X, Zhang Y. 2009. Antioxidant capacity of extract from edible flowers of Prunus mume in China and its active components. LWT-Food Sci. Technol. 42: 477-482. DOI ScienceOn |
15 | Sun H, Hou H, Lu P, Zhang L, Zhao F, Ge C, et al. 2012. Isocorydine inhibits cell proliferation in hepatocellular carcinoma cell lines by inducing G2/M cell cycle arrest and apoptosis. PLoS One 7: e36808. DOI |
16 | Yao Y, Zhang YW, Sun LG, Liu B, Bao YL, Lin H, et al. 2012. Juglanthraquinone C, a novel natural compound derived from Juglans mandshurica Maxim, induces S phase arrest and apoptosis in HepG2 cells. Apoptosis 17: 832-841. DOI |
17 | Zhang W, Grasso L, McClain CD, Gambel AM, Cha Y, Travali S, et al. 1995. p53-independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/marcrophage differentiation. Cancer Res. 55: 668-674. |
18 | Lees E. 1995. Cyclin dependent kinase regulation. Curr. Opin. Cell Biol. 7: 773-780. DOI ScienceOn |
19 | Katsube T, Tabata H, Ohta Y, Yamasaki Y, Anuurad E, Shiwaku K, et al. 2004. Screening for antioxidant activity in edible plant products: comparison of low-density lipoprotein oxidation assay, DPPH radical scavenging assay, and Folin-Ciocalteu assay. J. Agric. Food. Chem. 52: 2391-2396. DOI ScienceOn |
20 | Khalil ML. 2006. Biological activity of bee propolis in health and disease. Asian Pac. J. Cancer Prev. 7: 22-31. |
21 | King RW, Jackson PK, Kirschner MW. 1994. Mitosis in transition. Cell 79: 563-571. DOI ScienceOn |
22 | Lee JH, Kim YC, Woo HJ. 1999. Study on the anti-cancer effect of Acanthopanax sessiliflorus. J. Korean Oriental Med. 20: 464-475. |
23 | McGowan CH, Russell P. 1993. Human Wee1 kinase inhibits cell division by phosphorylating p34cdc2 exclusively on Tyr 15. EMBO J. 12: 75-85. |
24 | Li BZ, Chen ZL, Shi SS, Feng XL, Tan XG, Zhou F, et al. 2013. Overexpression of Cdc25C predicts response to radiotherapy and survival in esophageal squamous cell carcinoma patients treated with radiotherapy followed by surgery. Chin. J. Cancer 32: 403-409. |
25 | Li Y, Jenkins CW, Nichols MA, Xiong Y. 1994. Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21. Oncogene 9: 2261-2268. |
26 | Malumbres M, Barbacid M. 2009. Cell cycle, CDKs and cancer: a changing paradigm. Nat. Rev. Cancer 9: 153-166. DOI ScienceOn |
27 | Meijer L. 1996. Chemical inhibitors of cyclin-dependent kinases. Trends Cell Biol. 6: 393-397. DOI ScienceOn |
28 | Morgan DO. 1995. Principles of CDK regulation. Nature 374: 131-134. DOI ScienceOn |
29 | Nasmyth K. 1996. Viewpoint: putting the cell cycle in order. Science 274: 1643-1645. DOI ScienceOn |
30 | Newman DJ, Cragg GM. 2007. Natural products as sources of new drugs over the last 25 years. J. Nat. Prod. 70: 461-477. DOI ScienceOn |
31 | Hartwell LH, Kastan MB. 1994. Cell cycle control and cancer. Science 266: 1821-1828. DOI |
32 | Festuccia C, Angelucci A, Gravina GL, Biordi L, Millimaggi D, Muzi P, et al. 2005. Epidermal growth factor modulates prostate cancer cell invasiveness regulating urokinase-type plasminogen activator activity. EGF-receptor inhibition may prevent tumor cell bissemination. Thromb. Haemost. 93: 964-975. |
33 | Green JR. 2004. Bisphosphonates: preclinical review. Oncologist 4: 3-13. |
34 | Hanahan D, Weinberg RA. 2000. The hallmarks of cancer. Cell 100: 57-65. DOI ScienceOn |
35 | Hartwell LH, Weinert TA. 1989. Checkpoints: controls that ensure the order of cell cycle events. Science 246: 629-633. DOI |
36 | Jin P, Gu Y, Morgan DO. 1996. Role of inhibitory CDC2 phosphorylation in radiation-induced G2 arrest in human cells. J. Cell Biol. 134: 963-970. DOI ScienceOn |
37 | Hassan BA, Yusoff ZB. 2010. Negative Impact of Chemotherapy on Breast Cancer Patients QOL - Utility of Antiemetic Treatment Guidelines and the Role of Race. Asian Pac. J. Cancer Prev. 11: 1523-1527. |
38 | Jermal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. 2011. Global cancer statistics. CA Cancer J. Clin. 61: 69-90. DOI |
39 | Jiang H, Lin J, Su ZZ, Collart FR, Huberman E, Fisher PB. 1994. Induction of differentiation in human promyelocytic HL- 60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene 9: 3397-3406. |
40 | Jin YS, Du JL, Yang Y, Jin L, Song Y, Zhang W, et al. 2011. Chemical and biologically active constituents of Salsola collina. Chem. Nat. Compd. 47: 257-260. DOI |
41 | Jo HJ, Song JD, Kim KM, Cho YH, Kim KH, Park YC. 2008. Diallyl disulfide induces reversible G2/M phase arrest on a p53-independent mechanism in human colon cancer HCT- 116 cells. Oncol. Rep. 19: 275-280. |
42 | Booher RN, Holman PS, Fattaey A. 1997. Human Myt1 is a cell cycle regulated kinase that inhibits Cdc2 but not Cdk2 activity. J. Biol. Chem. 272: 22300-22306. DOI |
43 | An Y. 1999. Prospective and retrospective studies on risk factors of four most common cancers in Korean males: stomach, live, lung and colorectum. Seoul, Ministry of Health & Welfare. |
44 | Aranha O, Wood DP Jr, Sarkar FH. 2000. Ciprofloxacin mediated cell growth inhibition, S/G2-M cell cycle arrest, and apoptosis in a human transitional cell carcinoma of the bladder cell line. Clin. Cancer Res. 6: 891-900. |
45 | Arellano M, Moreno S. 1997. Regulation of CDK/cyclin complexes during the cell cycle. Int. J. Biochem. Cell Biol. 29: 559-573. DOI ScienceOn |
46 | Byar KL, Berger AM, Bakken SL, Cetak MA. 2006. Impact of adjuvant breast cancer chemotherapy on fatigue, other symptoms, and quality of life. Oncol. Nurs. Forum 33: E18-26. DOI ScienceOn |
![]() |